Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway

Siegel, 2018, Cancer statistics, 2018, CA Cancer J. Clin., 68, 7, 10.3322/caac.21442 Rahib, 2014, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res., 74, 2913, 10.1158/0008-5472.CAN-14-0155 Ladomery, 2013, Aberrant alternative splicing is another hallmark of cancer, Int. J. Cell Biol., 2013, 10.1155/2013/463786 Lee, 2003, Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms, Ann. Thorac. Surg., 76, 213, 10.1016/S0003-4975(03)00319-9 Takano, 2016, Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization, Genes Dev., 30, 233, 10.1101/gad.263327.115 Swartz, 2002, MUC4 expression increases progressively in pancreatic intraepithelial neoplasia, Am. J. Clin. Pathol., 117, 791, 10.1309/7Y7N-M1WM-R0YK-M2VA Mukhopadhyay, 2013, MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells, PLoS One, 8, 10.1371/journal.pone.0054455 Rachagani, 2012, MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1, Carcinogenesis, 33, 1953, 10.1093/carcin/bgs225 Jonckheere, 2014, Mucins and tumor resistance to chemotherapeutic drugs, Biochim. Biophys. Acta, 1846, 142 Majhi, 2013, Pathobiological implications of MUC4 in non-small-cell lung cancer, J. Thorac. Oncol., 8, 398, 10.1097/JTO.0b013e3182829e06 Singh, 2007, Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy, Cancer Res., 67, 433, 10.1158/0008-5472.CAN-06-3114 Escande, 2002, Genomic organization of MUC4 mucin gene. Towards the characterization of splice variants, Eur. J. Biochem., 269, 3637, 10.1046/j.1432-1033.2002.03032.x Chaturvedi, 2008, Structure, evolution, and biology of the MUC4 mucin, FASEB J., 22, 966, 10.1096/fj.07-9673rev Moniaux, 2000, Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins, Eur. J. Biochem., 267, 4536, 10.1046/j.1432-1327.2000.01504.x Kumar, 2016, Genetic variants of mucins: unexplored conundrum, Carcinogenesis, 38, 671 Zrihan-Licht, 1994, Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue, Eur. J. Biochem., 224, 787, 10.1111/j.1432-1033.1994.00787.x Xie, 2014, Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4, Oncol. Rep., 31, 2187, 10.3892/or.2014.3113 Zhu, 2014, Pancreatic cancer counterattack: MUC4 mediates Fas-independent apoptosis of antigen-specific cytotoxic T lymphocyte, Oncol. Rep., 31, 1768, 10.3892/or.2014.3016 Chaturvedi, 2007, MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins, Mol. Cancer Res., 5, 309, 10.1158/1541-7786.MCR-06-0353 Hollingsworth, 2004, Mucins in cancer: protection and control of the cell surface, Nat. Rev. Cancer, 4, 45, 10.1038/nrc1251 Makiguchi, 1996, Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth, Jpn. J. Cancer Res., 87, 505, 10.1111/j.1349-7006.1996.tb00252.x Komatsu, 1997, Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex, J. Biol. Chem., 272, 33245, 10.1074/jbc.272.52.33245 Dickson, 2000, Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics, Mol. Cell. Biol., 20, 1436, 10.1128/MCB.20.4.1436-1447.2000 Senapati, 2012, Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells, Oncogene, 31, 3346, 10.1038/onc.2011.505 Moniaux, 2007, Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells, Br. J. Cancer, 97, 345, 10.1038/sj.bjc.6603868 Gomez-Martinez, 2013, Generation of stable human cell lines with Tetracycline-inducible (Tet-on) shRNA or cDNA expression, J. Vis. Exp., e50171 Macha, 2017, Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells, Oncotarget, 8, 20961, 10.18632/oncotarget.15468 Lakshmanan, 2016, MUC5AC interactions with integrin beta4 enhances the migration of lung cancer cells through FAK signaling, Oncogene, 35, 4112, 10.1038/onc.2015.478 Lee, 2015, Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin beta4 and Akt signals, Sci. Rep., 5 Lessan, 1999, CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells, Am. J. Pathol., 154, 1525, 10.1016/S0002-9440(10)65406-5 Das, 2015, Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells, Oncotarget, 6, 5772, 10.18632/oncotarget.3308 Moniaux, 2004, Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans, J. Histochem. Cytochem., 52, 253, 10.1177/002215540405200213 Rachagani, 2011, Activated KrasG(1)(2)D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin, Br. J. Cancer, 104, 1038, 10.1038/bjc.2011.31 Chaturvedi, 2008, MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells, Cancer Res., 68, 2065, 10.1158/0008-5472.CAN-07-6041 Bodary, 1990, The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line, J. Biol. Chem., 265, 5938 Bouchard, 2007, Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways, J. Cell. Physiol., 212, 717, 10.1002/jcp.21096 Santos, 2012, beta1 integrin-focal adhesion kinase (FAK) signaling modulates retinal ganglion cell (RGC) survival, PLoS One, 7, e48332, 10.1371/journal.pone.0048332 Gu, 2017, Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells, Oncotarget, 8, 90842, 10.18632/oncotarget.20412 Meloche, 2007, The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition, Oncogene, 26, 3227, 10.1038/sj.onc.1210414 Grzesiak, 2007, The integrin-extracellular matrix axis in pancreatic cancer, Pancreas, 35, 293, 10.1097/mpa.0b013e31811f4526 Li, 2015, Expression of CD44 in pancreatic cancer and its significance, Int. J. Clin. Exp. Pathol., 8, 6724 Lisabeth, 2013, Eph receptor signaling and ephrins, Cold Spring Harb. Perspect. Biol., 5, 10.1101/cshperspect.a009159 Biankin, 2012, Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes, Nature, 491, 399, 10.1038/nature11547 Kusamura, 2010, Pathophysiology and biology of peritoneal carcinomatosis, World J. Gastrointest. Oncol., 2, 12, 10.4251/wjgo.v2.i1.12 Jahan, 2016, 1 Ciborowski, 2002, Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis, Clin. Exp. Metastasis, 19, 339, 10.1023/A:1015590515957 Kohlgraf, 2003, Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line, Cancer Res., 63, 5011 Tang, 2016, The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer, J. Exp. Clin. Cancer Res., 35, 91, 10.1186/s13046-016-0369-0 Bendas, 2012, Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins, Int. J. Cell Biol., 2012, 676731, 10.1155/2012/676731 Barczyk, 2010, Integrins, Cell Tissue Res., 339, 269, 10.1007/s00441-009-0834-6 Lu, 2012, The extracellular matrix: a dynamic niche in cancer progression, J. Cell Biol., 196, 395, 10.1083/jcb.201102147 Stupack, 2002, Get a ligand, get a life: integrins, signaling and cell survival, J. Cell Sci., 115, 3729, 10.1242/jcs.00071 Grzesiak, 2011, Knockdown of the beta(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis, Int. J. Cancer, 129, 2905, 10.1002/ijc.25942 Bouchard, 2008, B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms, Apoptosis, 13, 531, 10.1007/s10495-008-0192-y Hazlehurst, 2000, Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR), Oncogene, 19, 4319, 10.1038/sj.onc.1203782 Reddig, 2005, Clinging to life: cell to matrix adhesion and cell survival, Cancer Metastasis Rev., 24, 425, 10.1007/s10555-005-5134-3 Deeb, 2015, Pulmonary metastases in pancreatic cancer, is there a survival influence?, J. Gastrointest. Oncol., 6, E48 Thomassen, 2013, Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study, Pancreas, 42, 72, 10.1097/MPA.0b013e31825abf8c Kaur, 2009, (beta)3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer, Am. J. Pathol., 175, 2184, 10.2353/ajpath.2009.090028 Arsic, 2012, A novel function for Cyclin A2: control of cell invasion via RhoA signaling, J. Cell Biol., 196, 147, 10.1083/jcb.201102085 Casimiro, 2012, Cyclins and cell cycle control in cancer and disease, Genes Cancer, 3, 649, 10.1177/1947601913479022 Ito, 2002, Expression of the G2-M modulators in pancreatic adenocarcinoma, Pancreatology, 2, 138, 10.1159/000055904